Gemcitabine and aspartate aminotransferase increased 
Gemcitabine and aspartate aminotransferase increased Patient Reports February 09, 2010
Gemcitabine Side Effects Report #5308407-5
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Apr 20, 2007. Female patient, 61 years of age, weighting 124.8 lb, was diagnosed with t-cell lymphoma refractory and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, disease progression, haematocrit decreased, haemoglobin decreased, platelet count decreased. Gemcitabine dosage: 1280 MG DAYS 1 + 8 IV DRIP. During the same period patient was treated with BORTEZOMIB. Patient recovered.
Gemcitabine Side Effects Report #5831843-5
Gemcitabine side effect was reported by a Physician from UNITED STATES on July 28, 2008. Male patient, weighting 193.0 lb, was diagnosed with renal cancer metastatic, insomnia, pain
and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, blood alkaline phosphatase increased, blood pressure increased, cardiomegaly, hypertension, leukoencephalopathy, mental status changes. Gemcitabine dosage: 1000 MG/M2, DAYS 1 AND 8. During the same period patient was treated with SUNITINIB MALATE, SUNITINIB MALATE, ATIVAN, PERCOCET, ASCORBIC ACID, CYANOCOBALAMIN, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.Gemcitabine Side Effects Report #5242254-8
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Feb 16, 2007. Male patient, 68 years of age, weighting 149.3 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain
, alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, back pain , blood alkaline phosphatase increased, fatigue, intestinal perforation, jaundice . Gemcitabine dosage: 800 MG/M2 D1 + D8 Q 21 DAYS IV. During the same period patient was treated with GLEEVEC. Patient was hospitalized. Patient recovered.Gemcitabine Side Effects Report #6120621-8
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Mar 12, 2009. Male patient, 76 years of age, weighting 158.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cholangitis, pyrexia. Gemcitabine dosage: unknown. During the same period patient was treated with TARCEVA, RADIATION, ASPIRIN, METOPROLOL TARTRATE, FLOMAX, ALPHAGAN, COSOPT, TRAVASTAN. Patient was hospitalized. Patient recovered.
Gemcitabine Side Effects Report #4717821-8
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2005. Male patient, weighting 178.8 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain
, anaemia, anorexia, aspartate aminotransferase increased, asthenia, atelectasis, blood albumin decreased, blood bilirubin increased, blood glucose increased. Gemcitabine dosage: unknown. Patient was hospitalized. Patient died on 06/24/2005.Gemcitabine Side Effects Report #4799886-0
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 26, 2005. Female patient, 65 years of age, weighting 121.3 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. Gemcitabine dosage: 1748 MG. During the same period patient was treated with CARBOPLATIN, RANITIDINE, DOSULEPIN, CITALOPRAM, SYMBICORT, ONDANSETRON. Patient was hospitalized. Patient recovered.
Gemcitabine Side Effects Report #4937401-9
Gemcitabine side effect was reported by a Consumer or non-health professional from HONG KONG on Feb 21, 2006. Male patient, 65 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatomegaly, metastases to liver. Gemcitabine dosage: 1250 MG/M2,. During the same period patient was treated with CARBOPLATIN. Patient died on 02/18/2006.
Gemcitabine Side Effects Report #4831116-3
Gemcitabine side effect was reported by a Physician from KOREA, REPUBLIC OF on Nov 04, 2005. Female patient, 48 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, constipation
, granulocytopenia, haematotoxicity, nausea . Gemcitabine dosage: 1600 MG/8. During the same period patient was treated with CISPLATIN, GRANISETRON, DEXAMETHASONE, METOCLOPRAMIDE, OXYCODONE. Patient recovered.Gemcitabine Side Effects Report #5133980-X
Gemcitabine side effect was reported by a Physician from GERMANY on Oct 02, 2006. Male patient, 46 years of age, weighting 196.2 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, lipase increased. Gemcitabine dosage: 100 MG/M2,. During the same period patient was treated with CETUXIMAB. Patient recovered.
Gemcitabine Side Effects Report #4806747-7
Gemcitabine side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on July 07, 2005. Female patient, 46 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, constipation
, granulocytopenia, haematotoxicity, nausea . Gemcitabine dosage: unknown. During the same period patient was treated with CISPLATIN, GRANISETRON, DEXAMETHASONE, METOCLOPRAMIDE, OXYCODONE. Patient recovered.Gemcitabine Side Effects Report #4827667-8
Gemcitabine side effect was reported by a Physician from KOREA, REPUBLIC OF on Nov 04, 2005. Female patient, 44 years of age, weighting 103.6 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, metastases to liver. Gemcitabine dosage: 1500 MG/9. During the same period patient was treated with GRANISETRON, WARFARIN. Patient died on 12/09/2004.
Gemcitabine Side Effects Report #4831017-0
Gemcitabine side effect was reported by a Physician from KOREA, REPUBLIC OF on Nov 04, 2005. Female patient, 43 years of age, weighting 114.6 lb, was diagnosed with non-small cell lung cancer and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, pharyngotonsillitis. Gemcitabine dosage: 1500 MG/17. During the same period patient was treated with GRANISETRON, LORAZEPAM. Patient recovered.
Gemcitabine Side Effects Report #4673377-X
Gemcitabine side effect was reported by a Consumer or non-health professional from on May 20, 2005. Female patient, 68 years of age, weighting 112.0 lb, was diagnosed with mesothelioma
and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, ultrasound scan abnormal. Gemcitabine dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient recovered.Gemcitabine Side Effects Report #4828119-1
Gemcitabine side effect was reported by a Physician from GERMANY on Nov 04, 2005. Male patient, 88 years of age, was diagnosed with mantle cell lymphoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, cardiac failure, haematocrit decreased, haemoglobin decreased. Gemcitabine dosage: unknown. During the same period patient was treated with LASIX, PANTOPRAZOLE, FABAHISTIN, BETAHISTINE, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.
Gemcitabine Side Effects Report #4830721-8
Gemcitabine side effect was reported by a Consumer or non-health professional from GERMANY on Nov 09, 2005. Male patient, 88 years of age, was diagnosed with mantle cell lymphoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain
, aspartate aminotransferase increased, cardiac failure, haematocrit decreased, haemoglobin decreased, pleural disorder . Gemcitabine dosage: unknown. During the same period patient was treated with LASIX, PANTOPRAZOLE, BETAHISTINE, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.Gemcitabine Side Effects Report #4789406-9
Gemcitabine side effect was reported by a Physician from UNITED STATES on Sept 21, 2005. Female patient, 57 years of age, was diagnosed with breast cancer recurrent and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, atrioventricular block complete, blood alkaline phosphatase increased, blood bilirubin increased, breast cellulitis, cardiac failure congestive, cardiomegaly. Gemcitabine dosage: 1250 MG/M2 OTHER. During the same period patient was treated with PACLITAXEL, EMEND, TESSALON, ZOFRAN, EXTRA STRENGTH TYLENOL, MOTRIN, TUSSIONEX, ALOXI. Patient was hospitalized. Patient recovered.
Gemcitabine Side Effects Report #4719464-9
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on June 30, 2005. Female patient, 49 years of age, weighting 220.5 lb, was diagnosed with breast cancer metastatic and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cellulitis
, disease recurrence, erythema nodosum, haemoglobin decreased, pyrexia, rash . Gemcitabine dosage: 1250 MG/M2. During the same period patient was treated with HERCEPTIN, AREDIA, ARANESP, XANAX, LOPRESSOR. Patient was hospitalized. Patient recovered.Gemcitabine Side Effects Report #5113297-X
Gemcitabine side effect was reported by a Physician from UNITED STATES on Aug 31, 2006. Female patient, 60 years of age, weighting 169.8 lb, was diagnosed with breast cancer
and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood pressure increased, cellulitis , diarrhoea, erythema marginatum, haemoglobin decreased, hyperglycaemia. Gemcitabine dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, MEDROL ACETATE, CLINDAMYCIN, COMBIVENT, RELAFEN. Patient was hospitalized. Patient recovered.Gemcitabine Side Effects Report #5123161-8
Gemcitabine side effect was reported by a Physician from UNITED STATES on Sept 13, 2006. Female patient, 60 years of age, weighting 169.8 lb, was diagnosed with breast cancer
and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cellulitis , diarrhoea, erythema marginatum, hyperglycaemia, hypertension. Gemcitabine dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with PACLITAXEL, MEDROL, CLINDAMYCIN, COMBIVENT, RELAFEN. Patient was hospitalized. Patient recovered.Gemcitabine Side Effects Report #6124535-9
Gemcitabine side effect was reported by a Pharmacist from UNITED STATES on Mar 17, 2009. Male patient, 55 years of age, weighting 224.9 lb, was diagnosed with breast cancer
and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased. Gemcitabine dosage: 2280MG ONCE IV DRIP. During the same period patient was treated with TRASTUZUMAB, DEXAMETHASONE, ONDANSETRON, HEPARIN, CHLORIDE. Patient died on 03/15/2009.Gemcitabine Side Effects Report #4968741-5
Gemcitabine side effect was reported by a Physician from UNITED KINGDOM on Mar 14, 2006. Female patient, 54 years of age, weighting 174.2 lb, was diagnosed with breast cancer
and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain , aspartate aminotransferase increased, diarrhoea, dizziness , dyspnoea at rest, gamma-glutamyltransferase increased, headache , infection , liver function test abnormal. Gemcitabine dosage: 2310 MG. During the same period patient was treated with PACLITAXEL, EPIRUBICIN, CYCLOPHOSPHAMIDE, ADCAL, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Gemcitabine Side Effects Report #5052957-6
Gemcitabine side effect was reported by a Physician from GERMANY on June 19, 2006. Female patient, weighting 143.3 lb, was diagnosed with breast cancer
and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct stenosis, biliary dilatation, gamma-glutamyltransferase increased, neutropenia, pancreatic duct obstruction. Gemcitabine dosage: 1700 MG, INTRAVENOUS. During the same period patient was treated with GRANOCYTE, DEXAMETHASONE, NAVOBAN. Patient was hospitalized. Patient recovered.Gemcitabine Side Effects Report #5129113-6
Gemcitabine side effect was reported by a Health Professional from GERMANY on Sept 18, 2006. Female patient, weighting 198.4 lb, was diagnosed with breast cancer
and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, periodontitis, sinusitis , tooth loss. Gemcitabine dosage: 1890 MG, INTRAVENOUS; SEE IMAGE. During the same period patient was treated with DEXAHEXAL, KEVATRIL. Patient was hospitalized. Patient recovered.Gemcitabine Side Effects Report #5036584-2
Gemcitabine side effect was reported by a Physician from GERMANY on June 06, 2006. Female patient, weighting 143.3 lb, was diagnosed with breast cancer
and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, biliary dilatation, gamma-glutamyltransferase increased. Gemcitabine dosage: 1700 MG INTRAVENOUS. During the same period patient was treated with DOCETAXEL, GRANOCYTE. Patient was hospitalized. Patient recovered.Gemcitabine Side Effects Report #5104676-5
Gemcitabine side effect was reported by a Health Professional from UNITED STATES on Aug 22, 2006. Female patient, 62 years of age, was diagnosed with adenocarcinoma pancreas, pancreatic carcinoma and was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, back pain
, biliary tract disorder, blood glucose increased, fall , reversible posterior leukoencephalopathy syndrome, stent placement. Gemcitabine dosage: 1750 MG, INTRAVENOUS. During the same period patient was treated with OXALIPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.Gemcitabine Side Effects Report #5015908-6
Gemcitabine side effect was reported by a Physician from FRANCE on May 09, 2006. Female patient, 75 years of age, weighting 132.3 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bladder obstruction, blood creatine increased, myocardial ischaemia, pleural effusion, pneumonia
. Gemcitabine dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with CREON, VITAMIN D, OSTRAM, ATARAX, RYTHMOL, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Gemcitabine Side Effects Report #6122068-7
Gemcitabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 16, 2009. Female patient, weighting 174.2 lb, was treated with Gemcitabine. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chest pain
, cholelithiasis, pyrexia. Gemcitabine dosage: 4368 MG. During the same period patient was treated with CISPLATIN, DIFLUCAN. Patient was hospitalized. Patient recovered.